?? Exciting News in PGx! ?? We are thrilled to announce the launch of an advanced solution in pharmacogenetic analysis—VeriDose? Core v2.0! ?? What’s new?? ?? Updated gene targets aligned with AMP Tier 1 and Tier 2 recommendations? ?? Obtain genotype and CNV calling simultaneously when run with VeriDose CYP2D6 CNV v2.0 Panel ?? Enhanced software features for a smoother workflow Whether you’re looking to upgrade your existing panel or integrate a new solution, VeriDose Core v2.0 is designed to elevate your research. Ready to take your testing to the next level? Contact us today to learn more: https://bit.ly/3NQckkF #PGx #Pharmacogenetics #VeriDoseCore #MassARRAY?
Agena Bioscience
生物技术研究
San Diego，California 8,152 位关注者
A molecular diagnostics company dedicated to advancing the impact of genomics in healthcare and precision medicine.
关于我们
Agena Bioscience? empowers research laboratories worldwide to deliver scalable targeted genomic data. Our advanced platforms deliver timely molecular insights in the areas of mutation profiling, liquid biopsy, pharmacogenetics, and more. Agena offers the MassARRAY? System, an open platform that provides researchers with insights through a highly multiplexed solution. Headquartered in San Diego, with offices located around the world, Agena Bioscience fosters a highly collaborative culture for both our customers and employees, encouraging diversity, creativity, and most importantly, innovation.
- 网站
-
https://agenabio.com
Agena Bioscience的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- San Diego，California
- 类型
- 私人持股
- 领域
- Gene expression、SNP genotyping、Sample quantitation、Copy number variation、Analytical instruments、Lab equipment、Life science research、Applied testing、Pharmaceutical research、Liquid Biopsy、Pharmacogenomics、Mutation Profiling、Sample Integrity、Specimen Validity、Hereditary Genetics、Methylation、Chimerism、Blood Typing和Custom Assays
地点
Agena Bioscience员工
动态
-
Exciting news coming out of AMP 2024: Announcing a strategic partnership and presentation with Agena Bioscience to bridge critical gaps in detecting mutations not identified by next-generation sequencing (NGS) alone. https://hubs.ly/Q02YV4vF0 #AMP #next-generation sequencing
-
-
?? Spotted at #AMP2024: Great workshops featuring leading experts in oncology and pharmacogenomics. ?? Got questions about genomic analysis workflows? Our team at Booth 925 has answers! Stop by for a chat about: - Sample optimization? - Research efficiency? - High-throughput solutions? - Quality assurance? - And more!
-
-
?? Something's poppin' at #AMP2024! Visit Booth 925 for: - Fresh, hot popcorn? - Fresh perspectives on genomic analysis? - Fresh solutions for your research The perfect combo of treats and technology!? #AgenaBioscience #AMP2024?
-
-
Congratulations to Precision's Darren W. Davis, PhD on his presentation at AMP yesterday with Agena Bioscience presenting methods to bridge critical gaps in detecting mutations not identified by next-generation sequencing (NGS) alone. Got questions for Darren or our team? Stop by Booth 1311 or reach out to set up time to speak with Darren Davis, Glen Ferguson, Rob Fannon, Kristi Garner and Brian Hart. #AMP2024
-
-
?? We're getting ready for #AMP2024! Stop by Booth 925 later this week to explore innovative solutions for genomic research and discover how we're advancing multi-gene analysis. See you there!? #GenomicResearch #AMP2024?
-
-
Who will be at AMP 2024? Swing by booth #925 to connect with our team and explore our latest solutions in oncology, pharmacogenomics, and more. Whether you're looking to streamline your workflows, improve testing analysis, or simply learn about the latest innovations, we've got something for you. Let’s chat and see how we can help your lab achieve its goals. ? See you at AMP 2024—we can’t wait to meet you! #AMP2024 #Oncology #Pharmacogenetics?
-
-
Looking for a more efficient mutation profiling platform for breast and lung cancer research? If so, you’ll want to check out these two posters at this year’s Association for Molecular Pathology (AMP) Annual Meeting & Expo: ? Detection of common hotspot variants in PIK3CA and TP53 using Agena ClearSEEK? on the MassARRAY? System (ST085). This study, in collaboration with the University of Tübingen, looks at how the Agena ClearSEEK PIK3CA and the Agena Custom ClearSEEK TP53 panels stack up against digital droplet PCR in profiling FFPE breast cancer samples. A comprehensive evaluation of a rapid, low DNA input and cost-effective, targeted lung panel using MassARRAY technology to identify clinically relevant somatic variants in lung cancer (ST001). This poster describes a somatic variant profiling comparison study of an Augusta University developed LDT using iPlex HS chemistry on the MassARRAY system to NGS in FFPE lung cancer samples. We hope to see you at AMP next week! Drop by our booth (#925) to say hello and learn more about MassARRAY technology. If you can’t make it to AMP, comment below to get more information about the posters and Agena’s oncology and PGx solutions.? ?? #AMP2024 #MutationProfiling #Oncology?
-
Looking to decrease your QNS rate when performing molecular testing on solid tumor samples? Agena has partnered with Precision For Medicine, a global contract research organization, to evaluate an option for doing just that, and we are excited to present the results at the upcoming Association for Molecular Pathology (AMP) Annual Meeting & Expo. If you will be at AMP, be sure to check out our poster presentation of the study data: The Agena iPLEX HS Lung Panel on the MassARRAY? System is Able to Robustly Characterize the Molecular Profile of FFPE-Derived Lung Tumor Samples Previously Deemed QNS on Multiple NGS Platforms (ST143). ? Not making it to AMP this year? Comment below and we’ll give you more information on the study, the iPLEX HS Lung Panel, and how Agena can help you get data from more samples. #AMP2024 #Oncology #MutationProfiling?
-
Announcing a must-attend #PGx workshop at #AMP2024! Dr. Chad Bousman and former AMP president, Dr. Vicky Pratt, present: "Guideline-Driven PGx Testing: Covering? AMP Tier 1 & 2 Recommendations" Discover:? ?? VeriDose Core v2.0 PGx Panel?? ?? Implementation strategies?? ?? Standardization best practices?? ?? Evidence-based approaches Reserve your spot: https://bit.ly/3O6fqBb #Pharmacogenetics #MolecularAnalysis #ResearchLab #PGx?
-